In Silico Design and Evaluation of PRAME+FliCΔD2D3 as a New Breast Cancer Vaccine Candidate

BACKGROUND: The most prevalent cancer in women over the world is breast cancer. Immunotherapy is a promising method to effectively treat cancer patients. Among various immunotherapy methods, tumor antigens stimulate the immune system to eradicate cancer cells. Preferentially expressed antigen in mel...

Descripción completa

Detalles Bibliográficos
Autores principales: Taheri-Anganeh, Mortaza, Savardashtaki, Amir, Vafadar, Asma, Movahedpour, Ahmad, Shabaninejad, Zahra, Maleksabet, Amir, Amiri, Ahmad, Ghasemi, Younes, Irajie, Cambyz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shiraz University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812496/
https://www.ncbi.nlm.nih.gov/pubmed/33487792
http://dx.doi.org/10.30476/ijms.2019.82301.1029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812496/
https://www.ncbi.nlm.nih.gov/pubmed/33487792
http://dx.doi.org/10.30476/ijms.2019.82301.1029

Ejemplares similares